Argentina Becomes First Latin American Country to Register Sputnik V Vaccine

The Russian Direct Investment Fund (RDIF) announced on December 23, 2020, the Sputnik V vaccine registration by The National Administration of Drugs, Foods, and Medical Devices of Argentina (ANMAT). Sputnik V was registered under the emergency use authorization procedure and was approved by the regulator, ANMAT, based on the results of Phase III clinical trials in Russia, without additional trials in Argentina.

On December 10, 2020, the Government of Argentina signed a contract to purchase 10 million doses of the Sputnik V vaccine. These vaccines will be produced by RDIF's international partners in India, China, South Korea, and other countries.

Kirill Dmitriev, CEO of the RDIF, said in a press release, “The registration of the Sputnik V vaccine in Argentina without additional clinical trials in the country is a high recognition of Russian regulatory standards and the quality of clinical trials."